Circulating monocyte subsets with distinct functions play important roles in hepatitis C virus （HCV） infection. However, the mechanisms have not been well studied. In this study, we analyzed the distributions and ph...Circulating monocyte subsets with distinct functions play important roles in hepatitis C virus （HCV） infection. However, the mechanisms have not been well studied. In this study, we analyzed the distributions and phenotypic characteristics of three circulating monocyte subsets--CD14^＋＋CD16^-, CD14^＋＋CD16^＋ and CD14^＋＋mCD16^——in chronic HCV-infected patients, HCV spontaneous resolvers and healthy controls, and we evaluated the possible link between HCV viremia and disease progression. Our results indicated that the frequency of the CD 14^＋＋CD 16^＋ monocyte subset was decreased, and negatively correlated with HCV RNA and core antigen levels during chronic HCV infection. PD-L1 expression and the PD-L1/CD86 ratio in CD14^＋＋CD16^＋ monocytes were higher during chronic HCV infection than in spontaneous HCV resolvers and healthy controls. The PD-L1/CD86 ratio positively correlated with HCV viral load and core antigen levels. Finally, PD-L1 was significantly increased, while cytokine secretions were dramatically decreased upon Toll-like receptor （TLR） ligand binding and HCV JFH-lstimulation. These findings indicates the compromised immune status of the CD14^＋＋CD16^＋ monocytes during chronic HCV infection and provides new insights into the specific role of the CD14^＋＋CD16^＋ monocytes and their significance in chronic HCV infection.展开更多
目的研究细胞程序性死亡配体-1(programmed cell death protein ligand-1,PD-L1)功能抑制调控免疫活化影响ApoE^(-/-)小鼠动脉粥样硬化发生发展的机制。方法将24只ApoE^(-/-)小鼠随机分为正常组,高脂组和高脂^(+)抗PD-L1单抗组,通过高...目的研究细胞程序性死亡配体-1(programmed cell death protein ligand-1,PD-L1)功能抑制调控免疫活化影响ApoE^(-/-)小鼠动脉粥样硬化发生发展的机制。方法将24只ApoE^(-/-)小鼠随机分为正常组,高脂组和高脂^(+)抗PD-L1单抗组,通过高胆固醇饲料喂养建立动脉粥样硬化(atherosclerosis)模型。实验动物饲养70 d后,分离各组实验动物血管(主动脉根部至腹主动脉)及肝脏组织,进行油红O染色;HE染色检测肝组织病理改变;ELISA检测血清中总胆固醇(CHO)、甘油三酯(TG)、高密度脂蛋白(HDL-c)、低密度脂蛋白(LDL-c)和炎症因子(IFN-γ、TNF-α、IL-1β)含量。流式细胞计数检测肝脏淋巴细胞(CD4^(+)、CD8^(+)、CD4^(+)IFN-γ^(+)和CD8^(+)IFN-γ^(+)T细胞)。RT-PCR检测肝脏组织IFN-γ、TNF-α、IL-1β、CD4和CD8表达。结果与高脂组比较,给予抗PD-L1单抗后促血管壁及肝脏脂质累积并上调血清及肝组织CHO、TG、LDL-c和HDL-c含量。高脂饲养条件下给予抗PD-L1单抗促血清和肝组织谷丙转氨酶(GPT)和谷草转氨酶(GOT)含量升高,但是对碱性磷酸酶(AKP)含量没有影响。高脂饲养条件下给予抗PD-L1单抗促血清和肝脏组织IFN-γ、TNF-α和IL-1β含量升高。高脂饲养条件下给予抗PD-L1单抗抑制CD4表达及促CD8表达。高脂饲养条件下给予抗PD-L1单抗促肝脏CD8^(+)T和CD8^(+)IFN-γ^(+)T细胞活化,但是对CD4^(+)IFN-γ^(+)T细胞活化没有影响。结论高脂饲养条件下给予抗PD-L1单抗通过活化肝脏CD8^(+)IFN-γ^(+)T细胞损伤肝脏功能加重动脉粥样硬化。展开更多
目的探讨分化簇47(cluster of differentiation 47,CD47)与接受程序性死亡蛋白-1(programmed cell death protein 1,PD-1)/程序性死亡配体-1(programmed cell death ligand,PD-L1)抑制剂一线治疗的晚期非小细胞肺癌(Non-small cell lung...目的探讨分化簇47(cluster of differentiation 47,CD47)与接受程序性死亡蛋白-1(programmed cell death protein 1,PD-1)/程序性死亡配体-1(programmed cell death ligand,PD-L1)抑制剂一线治疗的晚期非小细胞肺癌(Non-small cell lung cancer,NSCLC)患者疗效及预后的相关性。方法收集2021年1月-2023年12月经湖南省邵阳市中心医院确诊为IIIB-IV期NSCLC且接受PD-1/PD-L1抑制剂一线治疗的116例患者的资料,获取患者的CD47蛋白表达情况并分析其与免疫治疗后疗效和预后的相关性。结果CD47阴性表达组患者的疾病控制率(disease control rate,DCR)高于阳性表达组(P=0.045)。在单因素生存分析中,CD47蛋白阴性表达患者的PFS优于CD47阳性表达组(P=0.002)。结论CD47蛋白阴性表达与晚期NSCLC患者接受免疫治疗后的疗效更好有关。展开更多
文摘Circulating monocyte subsets with distinct functions play important roles in hepatitis C virus （HCV） infection. However, the mechanisms have not been well studied. In this study, we analyzed the distributions and phenotypic characteristics of three circulating monocyte subsets--CD14^＋＋CD16^-, CD14^＋＋CD16^＋ and CD14^＋＋mCD16^——in chronic HCV-infected patients, HCV spontaneous resolvers and healthy controls, and we evaluated the possible link between HCV viremia and disease progression. Our results indicated that the frequency of the CD 14^＋＋CD 16^＋ monocyte subset was decreased, and negatively correlated with HCV RNA and core antigen levels during chronic HCV infection. PD-L1 expression and the PD-L1/CD86 ratio in CD14^＋＋CD16^＋ monocytes were higher during chronic HCV infection than in spontaneous HCV resolvers and healthy controls. The PD-L1/CD86 ratio positively correlated with HCV viral load and core antigen levels. Finally, PD-L1 was significantly increased, while cytokine secretions were dramatically decreased upon Toll-like receptor （TLR） ligand binding and HCV JFH-lstimulation. These findings indicates the compromised immune status of the CD14^＋＋CD16^＋ monocytes during chronic HCV infection and provides new insights into the specific role of the CD14^＋＋CD16^＋ monocytes and their significance in chronic HCV infection.
文摘目的研究细胞程序性死亡配体-1(programmed cell death protein ligand-1,PD-L1)功能抑制调控免疫活化影响ApoE^(-/-)小鼠动脉粥样硬化发生发展的机制。方法将24只ApoE^(-/-)小鼠随机分为正常组,高脂组和高脂^(+)抗PD-L1单抗组,通过高胆固醇饲料喂养建立动脉粥样硬化(atherosclerosis)模型。实验动物饲养70 d后,分离各组实验动物血管(主动脉根部至腹主动脉)及肝脏组织,进行油红O染色;HE染色检测肝组织病理改变;ELISA检测血清中总胆固醇(CHO)、甘油三酯(TG)、高密度脂蛋白(HDL-c)、低密度脂蛋白(LDL-c)和炎症因子(IFN-γ、TNF-α、IL-1β)含量。流式细胞计数检测肝脏淋巴细胞(CD4^(+)、CD8^(+)、CD4^(+)IFN-γ^(+)和CD8^(+)IFN-γ^(+)T细胞)。RT-PCR检测肝脏组织IFN-γ、TNF-α、IL-1β、CD4和CD8表达。结果与高脂组比较,给予抗PD-L1单抗后促血管壁及肝脏脂质累积并上调血清及肝组织CHO、TG、LDL-c和HDL-c含量。高脂饲养条件下给予抗PD-L1单抗促血清和肝组织谷丙转氨酶(GPT)和谷草转氨酶(GOT)含量升高,但是对碱性磷酸酶(AKP)含量没有影响。高脂饲养条件下给予抗PD-L1单抗促血清和肝脏组织IFN-γ、TNF-α和IL-1β含量升高。高脂饲养条件下给予抗PD-L1单抗抑制CD4表达及促CD8表达。高脂饲养条件下给予抗PD-L1单抗促肝脏CD8^(+)T和CD8^(+)IFN-γ^(+)T细胞活化,但是对CD4^(+)IFN-γ^(+)T细胞活化没有影响。结论高脂饲养条件下给予抗PD-L1单抗通过活化肝脏CD8^(+)IFN-γ^(+)T细胞损伤肝脏功能加重动脉粥样硬化。
文摘目的探讨分化簇47(cluster of differentiation 47,CD47)与接受程序性死亡蛋白-1(programmed cell death protein 1,PD-1)/程序性死亡配体-1(programmed cell death ligand,PD-L1)抑制剂一线治疗的晚期非小细胞肺癌(Non-small cell lung cancer,NSCLC)患者疗效及预后的相关性。方法收集2021年1月-2023年12月经湖南省邵阳市中心医院确诊为IIIB-IV期NSCLC且接受PD-1/PD-L1抑制剂一线治疗的116例患者的资料,获取患者的CD47蛋白表达情况并分析其与免疫治疗后疗效和预后的相关性。结果CD47阴性表达组患者的疾病控制率(disease control rate,DCR)高于阳性表达组(P=0.045)。在单因素生存分析中,CD47蛋白阴性表达患者的PFS优于CD47阳性表达组(P=0.002)。结论CD47蛋白阴性表达与晚期NSCLC患者接受免疫治疗后的疗效更好有关。
